Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
March 3, 2025
Medical Diagnostics & Screening
-
-
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
February 7, 2025
-
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
February 7, 2025
-
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
February 7, 2025
-
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base
February 6, 2025
-
Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
January 27, 2025
-
CENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital Partners
November 13, 2024
-
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection
October 15, 2024
-
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
-
Angle PLC Announces 100th Publication Supporting Parsortix System Use
September 26, 2024
-
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
August 19, 2024
-
Personalis and Tempus Announce Expanded Collaboration
August 16, 2024
-
Genetic Technologies Announces Global Launch of geneType(TM) on Wholly Owned EasyDNA platform
August 15, 2024
-
Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge
August 12, 2024
-
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
August 1, 2024
-
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
July 11, 2024